Dr. Wolters is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
513 parnassus ave
San Francisco, CA 94143Phone+1 415-353-4624Fax+1 415-353-2640
Education & Training
- University of California (San Francisco)Fellowship, Pulmonary Disease and Critical Care Medicine, 1998
- University of ColoradoResidency, Internal Medicine, 1992 - 1995
- University of Minnesota Medical SchoolClass of 1992
Certifications & Licensure
- CA State Medical License 1995 - 2026
- CO State Medical License 1994 - 1995
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 56 citationsOsteopontin Links Myeloid Activation and Disease Progression in Systemic SclerosisXia Gao, Guiquan Jia, Anna Guttman, Daryle Depianto, Katrina B. Morshead
Cell Reports. Medicine. 2020-11-17 - 51 citationsIntegrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severityShane Lofgren, Monique Hinchcliff, Mary Carns, Tammara A. Wood, Kathleen Aren
JCI Insight. 2016-12-22 - 2063 citationsReference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophageDvir Aran, Agnieszka P. Looney, Leqian Liu, Esther Wu, Valerie Fong
Nature Immunology. 2019-01-14
Journal Articles
- MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung DiseaseJay H Ryu, Deborah Assayag, Marvin I Schwarz, Paul Wolters, Andrew Gross, Ivan O Rosas, The New England Journal of Medicine
Press Mentions
- World's Leading Lung Disease Experts Join Numedii's Idiopathic Pulmonary Fibrosis Advisory BoardJanuary 8th, 2018
Grant Support
- Analysis Of Alveolar Type II Cells In Normal And Fibrotic Human LungNational Heart, Lung, And Blood Institute2011–2012
- MAST Cells And The Host Response In The LungNational Heart, Lung, And Blood Institute2004–2007
- MAST Cell Cysteine Proteases In Lung InflammationNational Heart, Lung, And Blood Institute1999–2003
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: